Altimmune

$11.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.63 (+5.70%) Today
-$0.12 (-1.03%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Altimmune and other stocks, options, and ETFs commission-free!

About ALT

Altimmune, Inc. Common Stock, also called Altimmune, is a clinical stage immunotherapeutic biotechnology company. Read More It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD. The listed name for ALT is Altimmune, Inc. Common Stock.

Employees
25
Headquarters
Gaithersburg, Maryland
Founded
1997
Market Cap
384.41M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.81M
High Today
$11.73
Low Today
$10.92
Open Price
$11.23
Volume
781.87K
52 Week High
$35.10
52 Week Low
$1.51

Collections

ALT Earnings

-$0.94
-$0.63
-$0.31
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 11, After Hours

You May Also Like